HM
CYTK icon

Harvest Management’s Cytokinetics CYTK Stock Holding History

Harvest Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,000
Closed -$351K – 48
2024
Q1 		$351K Sell
5,000
-7,000
-58% -$541K 0.24% 41
2023
Q4 		$1M Buy
+12,000
New +$435K 0.93% 23

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harvest Management's CYTK Position: Q2 2026 in Review

Harvest Management increased its Cytokinetics (CYTK) stake by 13% in Q2 2026, buying an estimated $101K and bringing the position to 12,400 shares worth $1.06M. The position accounts for 0.42% of the portfolio, ranked #32.

Harvest Management first reported a position in CYTK in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.25M in Q4 2023. 483 funds tracked by Wall St. Rank hold CYTK as of Q2 2026.

  • Harvest Management held 12,400 shares of Cytokinetics worth $1.06M as of Q2 2026.
  • Harvest Management bought 1,400 Cytokinetics shares in Q2 2026, an estimated $101K.
  • Cytokinetics made up 0.42% of Harvest Management's portfolio in Q2 2026, its #32 holding.
  • Harvest Management first reported a position in Cytokinetics in Q4 2023 and has held it in 11 quarters since.
  • Harvest Management's Cytokinetics position peaked at $1.25M in Q4 2023.
  • 483 funds tracked by Wall St. Rank held Cytokinetics as of Q2 2026.

Based on Harvest Management's 13F filing for Q2 2026, filed 14 Aug 2026.